产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
维持酶复合物(例如丙酮酸脱氢酶和甘氨酸脱羧酶的复合物)活性所需的抗氧化剂和辅酶。通过两种或多种酶的作用在细胞内还原外源性硫辛酸。然后,该还原形式通过直接清除自由基、循环利用其他抗氧化剂、增加谷胱甘肽的合成以及调控转录因子(尤其是 NF-κB)的活性而影响许多细胞过程。减少巨噬细胞对髓磷脂的吞噬。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAC6145 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
经验(实验)分子式 | C8H14O2S2 |
分子量 | 206.33 |
Beilstein | 81853 |
MDL编号 | MFCD00005474 |
产品性质
等级 | certified reference material pharmaceutical secondary standard |
描述 | Pharmaceutical Secondary Standard; Certified Reference Material |
形式 | powder |
CofA | current certificate can be downloaded |
包装 | pkg of 1 g |
药典可追溯性 | traceable to PhEur Y0000546 traceable to USP 1368201 |
储存温度 | 2-8℃ |
SMILES string | OC(=O)CCCCC1CCSS1 |
InChI | 1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10) |
InChI key | AGBQKNBQESQNJD-UHFFFAOYSA-N |
安全信息
象形图 | |
警示用语: | Warning |
危险声明 | H302 - H315 - H317 - H319 - H411 |
预防措施声明 | P273 - P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
危险分类 | Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 |
储存分类代码 | 13 - Non Combustible Solids |
WGK | WGK 2 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |